|
Case of Multiple Immunotherapy Toxicities |
11/01/2024 - 8:00am to 9:00am EDT |
|
What’s New in Myeloproliferative Neoplasms? An Update on Polycythemia Vera and Essential Thrombocythemia |
11/08/2024 - 8:00am to 9:00am EST |
|
Case on Mycoses Fungoides |
11/15/2024 - 8:00am to 9:00am EST |
|
Improving Patient Outcomes via Systemic Therapies for Unresectable Hepatobiliary Carcinoma |
11/21/2024 - 10:54am EST |
|
Improving Patient Outcomes via Systemic Therapies for Unresectable Hepatobiliary Carcinoma |
11/22/2024 - 8:00am to 9:00am EST |
|
Biomaker Testing in NSCLC |
12/06/2024 - 8:00am to 9:00am EST |
|
Reviving the BTK Target in MCL: Recalibrating the Treatment Sequence With Non-Covalent BTK Inhibitors in R/R Disease |
12/13/2024 - 8:00am to 9:00am EST |
|
ASH 2024 Updates |
12/20/2024 - 8:08am to 9:00am EST |
|
Case of Hodgkin’s Lymphoma |
01/10/2025 - 8:00am to 9:00am EST |
|
Novel Treatments for Newly Diagnosed Ph+CML-CP: Striking the Balance of Treatment with Patient Goals and QoL |
01/17/2025 - 8:00am to 9:00am EST |
Facebook
X
LinkedIn
Forward